The FDA issued two draft guidance documents on social media last week. The first guidance pertains to product claims and risk information on platforms such as Twitter and Google’s sponsored links, while the second guidance covers correcting misinformation that originates from independent third parties on the Internet and social media sites.  The FDA has opened up a comment period and will be accepting comments until September 16, 2014.

For additional information and a full analysis on both guidances, please read the latest post on our firm’s Life Sciences Legal Update blog.